Related Experiment Video
Updated: May 20, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Oxidized low density lipoprotein, stem cells, and atherosclerosis.
Hui Yang1, Ahmed Salah Salem Mohamed, Sheng-Hua Zhou
1Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Lipids in Health and Disease
|July 4, 2012
Summary
Oxidized low-density lipoprotein (ox-LDL) may worsen atherosclerosis by harming stem cells involved in vascular repair. This review explores the link between ox-LDL, stem cells, and atherosclerosis progression.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Atherosclerosis Pathogenesis
Background:
- Atherosclerosis is an inflammatory vascular disease linked to plaque formation and vulnerability.
- Stem cells play a role in vascular repair following injury.
- Oxidized low-density lipoprotein (ox-LDL) is a known risk factor for atherosclerosis.
Purpose of the Study:
- To review the intricate relationship between ox-LDL, stem cells, and the development of atherosclerosis.
- To explore potential mechanisms by which ox-LDL influences stem cell function in the context of atherosclerosis.
- To understand how ox-LDL's toxic effects on stem cells might drive atherosclerotic plaque progression.
Main Methods:
- Literature review synthesizing existing research on ox-LDL, stem cells, and atherosclerosis.
- Analysis of proposed mechanisms linking stem cell behavior to ox-LDL exposure and atherosclerotic outcomes.
- Examination of studies investigating the impact of ox-LDL on stem cell-mediated vascular repair.
Main Results:
- Ox-LDL contributes to atherosclerotic plaque formation and instability.
- Stem cells are implicated in the pathogenesis of atherosclerosis.
- Ox-LDL exerts toxic effects on stem cells, potentially impairing vascular repair mechanisms.
Conclusions:
- Ox-LDL may promote atherosclerosis progression by adversely affecting stem cells.
- Targeting the interaction between ox-LDL and stem cells could offer novel therapeutic strategies for atherosclerosis.
- Further research is warranted to fully elucidate the mechanisms involved.
Related Concept Videos
01:38Inflammation
Overview
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...